Akero Therapeutics, Inc. (AKRO)
NASDAQ: AKRO · Real-Time Price · USD
54.55
-0.08 (-0.15%)
At close: Dec 5, 2025, 4:00 PM EST
54.53
-0.02 (-0.04%)
After-hours: Dec 5, 2025, 5:40 PM EST
Akero Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -292.82 | -252.06 | -151.76 | -112.03 | -100.78 | -79.21 | |
| Depreciation & Amortization | 0.02 | 0.02 | 0.03 | 0.04 | 0.04 | 0.02 | |
| Other Amortization | 0.72 | 0.61 | 0.79 | 0.2 | - | - | |
| Asset Writedown & Restructuring Costs | - | 1 | - | - | - | - | |
| Loss (Gain) From Sale of Investments | -10.76 | -13.12 | -9.55 | -0.01 | 1.07 | 0.08 | |
| Stock-Based Compensation | 34.28 | 29.7 | 21.5 | 23.24 | 10.05 | 6.02 | |
| Other Operating Activities | 1.54 | 0.75 | 0.31 | 0.5 | 0.21 | 0.2 | |
| Change in Accounts Payable | -4.73 | 2.01 | -0.65 | 0.97 | 3.27 | 2.48 | |
| Change in Other Net Operating Assets | 21.6 | 0.99 | -6.03 | -5.43 | 6.45 | -0.4 | |
| Operating Cash Flow | -250.17 | -230.11 | -145.37 | -92.52 | -79.68 | -70.8 | |
| Capital Expenditures | - | -1 | - | - | - | -0.15 | |
| Investment in Securities | -330.79 | -108.71 | -223.62 | -63.83 | 42.28 | -9.61 | |
| Investing Cash Flow | -330.79 | -109.71 | -223.62 | -63.83 | 42.28 | -9.76 | |
| Long-Term Debt Issued | - | 10 | 15 | 10 | - | - | |
| Net Debt Issued (Repaid) | -37.4 | 10 | 15 | 10 | - | - | |
| Issuance of Common Stock | 478.93 | 436.69 | 339.09 | 246.5 | 1.12 | 203.96 | |
| Other Financing Activities | -0.61 | -0.84 | -0.78 | -0.86 | -0.52 | -0.85 | |
| Financing Cash Flow | 440.93 | 445.85 | 353.32 | 255.63 | 0.6 | 203.11 | |
| Net Cash Flow | -140.03 | 106.03 | -15.67 | 99.29 | -36.8 | 122.54 | |
| Free Cash Flow | -250.17 | -231.11 | -145.37 | -92.52 | -79.68 | -70.95 | |
| Free Cash Flow Per Share | -3.20 | -3.44 | -2.77 | -2.37 | -2.29 | -2.25 | |
| Cash Interest Paid | 4.25 | 3.98 | 2.48 | 0.44 | - | - | |
| Levered Free Cash Flow | -156.88 | -148.48 | -94.05 | -53.51 | -43.22 | -41.98 | |
| Unlevered Free Cash Flow | -154.71 | -146.17 | -92.56 | -53.25 | -43.22 | -41.98 | |
| Change in Working Capital | 16.87 | 3 | -6.67 | -4.46 | 9.73 | 2.09 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.